Insider Transactions Reported by 8 Insiders of CASI Pharmaceuticals, Inc (DE)

Location
Rockville, MD

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

CASI Pharmaceuticals, Inc (DE) executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ph.D. WEI-WU HE Chairman and CEO, Director, 10%+ Owner $2,107,299 13 Jun 2022
James Huang Director $1,137,426 06 Sep 2022
Larry Zhang President 24 Jul 2021
Yue Alexander Wu Director 25 May 2022
Alexander A. Zukiwski EVP and Chief Medical Officer 07 Sep 2022
Rajesh Shrotriya Director 25 May 2022
Quan Zhou Director 25 May 2022
Franklin Cary Salisbury jr Director 25 May 2022

Recent Insider Transactions by Companies or Individuals for CASI Pharmaceuticals, Inc (DE)

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.